Skip links

Evkeeza® (evinacumab-dgnb)

Full Name Evkeeza® (evinacumab-dgnb)
Drug Evkeeza
Manufacturer Regeneron Pharmaceuticals
Route of Administration Intravenous
Site of Care Home or Healthcare Facility
Approved Indication Adjunct to other low-density lipoprotein-cholesterol (LDL-C) lowering therapies for the treatment of adult and pediatric patients, aged 12 years and older, with homozygous familial hypercholesterolemia (HoFH)
Disease Homozygous Familial Hypercholesterolemia (HoFH)
Therapeutic Area Cardiology
Enrollment Form Link Enrollment Form
Phone Number 800-645-4142
Fax Number 877-473-0199
Product Website